DR3/TNFRSF25 RNAi Summary
Homo sapiens tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 3, mRNA
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Concentration is not relevant for this product. Please see the protocols for proper use of this product.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for DR3/TNFRSF25 RNAi
- Apoptosis-inducing receptor AIR
- Apoptosis-mediating receptor DR3
- Apoptosis-mediating receptor TRAMP
- Death receptor 3
- DR3member 12 (translocatingchain-association membrane protein)
- Lymphocyte-associated receptor of death
- Protein WSL
- Protein WSL-1
- tumor necrosis factor receptor superfamily, member 25
Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. RNAi are guaranteed
for 3 months from date of receipt.
Customers Who Viewed This Item Also Viewed...
Applications: WB, ELISA, IHC, IHC-P, S-ELISA
Applications: WB, IHC, Neut
Applications: WB, Flow, ICC/IF, IHC-P
Applications: WB, ICC/IF
Applications: WB, IHC, IHC-P
Applications: WB, ELISA
Species: Hu, Mu
Applications: WB, ChIP, ICC/IF, IP
Applications: B/N, ELISA, Flow, ICC/IF, IHC, IHC-Fr, IP, Flow-IC
Applications: ICC/IF, IHC-Fr, IHC-P
Species: Hu, Mu, Rt
Applications: WB, ELISA, ICC/IF
Species: Hu, Mu, Rt, Ca, Rb
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
Applications: Flow, Neut
Applications: WB, Flow, IHC-P
Applications: ICC/IF, IHC, IHC-P
Publications for DR3/TNFRSF25 RNAi (H00008718-R04) (0)
There are no publications for DR3/TNFRSF25 RNAi (H00008718-R04).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for DR3/TNFRSF25 RNAi (H00008718-R04) (0)
There are no reviews for DR3/TNFRSF25 RNAi (H00008718-R04).
By submitting a review earn points towards our Rewards Program.
- 250 points for product review
- 500 additional points for an image with your product review
- Double points (500) if you are the first to review this product
- Double points (1000) if you are the first to review this product with an image
FAQs for DR3/TNFRSF25 RNAi (H00008718-R04) (0)
Additional DR3/TNFRSF25 RNAi Products
Related Products by Gene
Bioinformatics Tool for DR3/TNFRSF25 RNAi (H00008718-R04)
Discover related pathways, diseases and genes to DR3/TNFRSF25 RNAi (H00008718-R04). Need help?
Read the Bioinformatics Tool Guide
for instructions on using this tool.
Blogs on DR3/TNFRSF25